Happy to see our own Varvara Paraskevopoulou representing blood cancer at Fusion Conferences "Animal Models of Cancer"! Dont forget: Leukemia is a cancer and it has it's microenvironment 😀! Thanks Kevin Haigis Lab & Julien Sage for inviting Varvara! #AifantisLab NYU GSOM Pathology #CancerResearch

Excited for our latest work biorxiv.org/content/10.110… with Effie Apostolou & Aristotelis Tsirigos. We study the role of 3D hubs & enhancer rewiring in early developmental lineages & introduce 3D-HiChAT machine learning approach to nominate impactful enhancers for gene regulation.

Preprint📢 #Inflammation causes the body to remembers to fight better next time. Here we found that skin inflammation doesn't boost immune memory like we thought—it can also dampen it! Find out how this surprising result could change our grasp of #Immunity biorxiv.org/cgi/content/sh…

Excited to see our story showing that the #stressresponse regulator #HSF1 modulates NK cell anti-tumour immunity out in ⁦Nature Cell Biology⁩. Thanks to fantastic work with ⁦Nikos Kourtis⁩ ⁦Iannis Aifantis⁩ and team ⁦NYU Langone Health⁩ 🧵👇 nature.com/articles/s4155…

Out today at Nature Immunology our extensive review of the immune micro-environment in human leukemia. Prepared by Zoe and Varvara in the #AifantisLab. Its been a decade-long trip to demonstrate that -like solid tumors- leukemia has specific niches in tissues and directly interacts

Excited to share our review on the immune microenvironment in leukemia, with Zoe & Iannis Aifantis, out in Nature Immunology. #AifantisLab #tumormicroenvironment #leukemia nature.com/articles/s4159…

Excited to share with all our latest work on the use of single cell tools in following IDH mutant AML patients during their treatment! Out today Cell Stem Cell !! An amazing collaboration with AK Eisfeld & Elli Papaemmanuil, PhD & Dan Landau !!! Driven by the impressive Maria Sirenko

Delighted to share our study out in Cell Stem Cell today from the dream team Elli Papaemmanuil, PhD Iannis Aifantis AK Eisfeld Dan Landau! We profiled IDH-mutated AML patients to define how IDH and co-mutations shape the disease at baseline and responses to IDH-inhibitors. 🧵👇